<DOC>
	<DOCNO>NCT02187068</DOCNO>
	<brief_summary>The aim study characterize , use two different model approach , one base purely statistic concept one use mechanistic analysis , influence body weight composition pharmacokinetic dexmedetomidine .</brief_summary>
	<brief_title>Dexmedetomidine Pharmacokinetics Obese</brief_title>
	<detailed_description>Twenty obese patient 20 non-obese patient schedule elective laparoscopic surgery give dexmedetomidine 0.5 Î¼g.kg-1 10 minute randomize either dexmedetomidine 0.25 mcg.kg-1.h-1 dexmedetomidine 0.5 mcg.kg-1.h-1 approximate 2 h ( range 58-320 min ) . Blood sample take 2 , 5 , 10 , 15 , 20 , 30 , 45 , 60 , 90 , 120 min begin dexmedetomidine administration , 0 , 2 , 5 , 10 , 20 , 30 , 60 , 90 , 120 , 240 360 min stop infusion . Population pharmacokinetic modeling perform use nonlinear mixed-effects model .</detailed_description>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>American Society Anesthesiologist classification IIII patient 18 60 year age schedule elective laparoscopic surgery obese patient BMI &gt; 35 kg m2 ( 20 patient ) nonobese patient ( BMI 18.525 kg m2 ) ( 20 patient ) know allergy study drug uncontrolled hypertension heart block great first degree take drug act central nervous system 24 h surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Anaesthetics iv</keyword>
	<keyword>Dexmedetomidine</keyword>
	<keyword>Pharmacokinetic</keyword>
</DOC>